Literature DB >> 32536719

Solubility Determination and Correlation of Warfarin Sodium 2‑Propanol Solvate in Pure, Binary, and Ternary Solvent Mixtures.

Mery Vet George De la Rosa1,2, Roberto Santiago2,3, Joseph Malavé Romero2,4, Jorge Duconge1, Jean-Christophe Monbaliu5, Vilmalí López-Mejías2,6, Torsten Stelzer1,2.   

Abstract

The solubility of warfarin sodium isopropanol solvate (WS·IPA), a widely used anticoagulant, was determined at temperatures ranging from 278.15 to 333.15 K in four pure solvents (acetone, ethanol, IPA, and water), five binary solvent mixtures (IPA + acetone, IPA + ethanol, IPA + water, IPA + heptane, and IPA + hexane), and five ternary solvent mixtures (IPA + acetone + heptane, IPA + acetone + hexane, IPA + ethanol + heptane, IPA + ethanol + hexane, and IPA + water + heptane) using the polythermal method. It was demonstrated that the solubility of WS·IPA increases with increasing temperature in the pure solvents and at constant solvent composition in the solvent mixtures. In addition, the solubility of WS·IPA in IPA increases with increasing content of acetone, ethanol, and water, which act as cosolvents, and decreases with increasing content of heptane and hexane, which act as antisolvents. The experimental solubility data of WS·IPA in pure solvents and binary and ternary solvent mixtures were correlated using the modified Apelblat and λh model equations. The correlated solubility data agree with the experimental data based on the relative deviation and the average relative deviation (ARD %) values. Thus, the correlated and experimentally derived solubility data of WS·IPA provide a pathway to engineer advanced pharmaceutical crystallization processes for WS·IPA.

Entities:  

Year:  2019        PMID: 32536719      PMCID: PMC7291792          DOI: 10.1021/acs.jced.8b00977

Source DB:  PubMed          Journal:  J Chem Eng Data        ISSN: 0021-9568            Impact factor:   2.694


  13 in total

1.  Solubilization by cosolvents. Establishing useful constants for the log-linear model.

Authors:  Jeffrey Millard; F Alvarez-Núñez; S Yalkowsky
Journal:  Int J Pharm       Date:  2002-10-01       Impact factor: 5.875

2.  Understanding effect of formulation and manufacturing variables on the critical quality attributes of warfarin sodium product.

Authors:  Ziyaur Rahman; Maxwell Korang-Yeboah; Akhtar Siddiqui; Adil Mohammad; Mansoor A Khan
Journal:  Int J Pharm       Date:  2015-08-28       Impact factor: 5.875

3.  On-demand continuous-flow production of pharmaceuticals in a compact, reconfigurable system.

Authors:  Andrea Adamo; Rachel L Beingessner; Mohsen Behnam; Jie Chen; Timothy F Jamison; Klavs F Jensen; Jean-Christophe M Monbaliu; Allan S Myerson; Eve M Revalor; David R Snead; Torsten Stelzer; Nopphon Weeranoppanant; Shin Yee Wong; Ping Zhang
Journal:  Science       Date:  2016-04-01       Impact factor: 47.728

4.  Advanced Continuous Flow Platform for On-Demand Pharmaceutical Manufacturing.

Authors:  Ping Zhang; Nopphon Weeranoppanant; Dale A Thomas; Kohei Tahara; Torsten Stelzer; Mary Grace Russell; Marcus O'Mahony; Allan S Myerson; Hongkun Lin; Liam P Kelly; Klavs F Jensen; Timothy F Jamison; Chunhui Dai; Yuqing Cui; Naomi Briggs; Rachel L Beingessner; Andrea Adamo
Journal:  Chemistry       Date:  2018-01-31       Impact factor: 5.236

5.  Physical chemical stability of warfarin sodium.

Authors:  D Gao; M B Maurin
Journal:  AAPS PharmSci       Date:  2001

6.  Clathrates of sodium warfarin.

Authors:  C F Hiskey; V Melnitchenko
Journal:  J Pharm Sci       Date:  1965-09       Impact factor: 3.534

7.  Avoiding crystallization of lorazepam during infusion.

Authors:  J Vellema; N G M Hunfeld; H E A Van den Akker; J H ter Horst
Journal:  Eur J Pharm Sci       Date:  2011-10-17       Impact factor: 4.384

8.  Solid-state properties of warfarin sodium 2-propanol solvate.

Authors:  Agam R Sheth; William W Brennessel; Victor G Young; Francis X Muller; David J W Grant
Journal:  J Pharm Sci       Date:  2004-11       Impact factor: 3.534

9.  Influence of solvents on the variety of crystalline forms of erythromycin.

Authors:  Sabiruddin Mirza; Inna Miroshnyk; Jyrki Heinämäki; Leena Christiansen; Milja Karjalainen; Jouko Yliruusi
Journal:  AAPS PharmSci       Date:  2003

10.  Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.

Authors:  Yiwei Tian; Jonathan Booth; Elizabeth Meehan; David S Jones; Shu Li; Gavin P Andrews
Journal:  Mol Pharm       Date:  2012-12-07       Impact factor: 4.939

View more
  1 in total

1.  Solubility Measurements and Correlation of MBQ-167 in Neat and Binary Solvent Mixtures.

Authors:  Jocelyn M Jiménez Cruz; Cornelis P Vlaar; Vilmalí López-Mejías; Torsten Stelzer
Journal:  J Chem Eng Data       Date:  2020-12-10       Impact factor: 3.119

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.